Gene Therapy Europe: Online

Attracting leading experts & the brightest minds in the industry to educate, inform and excite our attendees.

The following were confirmed speakers for the 2020 Series.

Alan Smith

Executive Vice President, Technical Operations

Bellicum Pharmaceuticals

Alex Bloom

Vice President Regulatory Affairs and Quality Assurance

Gyroscope Therapeutics

Aline Hughson

Senior Process Scientist

Gyroscope Therapeutics

Amit Patel

Consultant, Cellular Therapies and Stem Cell Transplantation (Haematology Oncology), Intensive Care Medicine

NHS

Angela Columbano

Head of Business Development & Partnering

Genethon

Angeliki Grammenos

Manager Regulatory

Celyad

Annie Hubert

Senior Director, EU Section & Public Policy

Alliance for Regeneratice Medicine

Anthony Ting

Vice President of Regenerative Medicine, Head of Cardiopulmonary Programs

Athersys

Ashish Dugar

Vice President, Global Medical Affairs

Sarepta Therapeutics

Asli Akidil

Senior Scientist, Oncology Safety Combinations

AstraZeneca

Axel Böhnke

Director Market Access EU North

PTC Therapeutics

Barbara Kraus

Head of Gene Therapy Process Development

Takeda

Benjamin Moritz

Principal Scientist - Process Sciences

Ichnos Sciences SA

Benoit Moreaux

Chief Scientific and Technological Officer

Bone Therapeutics

Bo Kara

Vice President Process Development

Evox Therapeutics

Bobby Gaspar

Chief Executive Officer

Orchard Therapeutics

Britta Anderson

Senior R&D Scientist, Biopharmaceutical Expression Systems Team

Merck KGaA

Celine Dumont

Senior Director, Preclinical, Pharmacology and Safety

Sangamo Therapeutics

Chaminda Salgado

Scientific leader, Cell & Gene Therapy Platform CMC

GlaxoSmithKline

Chantale Julien

Product Manager

Novo Nordisk Pharmatech A/S

Chris Bond

Vice President, Cell ular Engineering

Kite, A Gilead Company

Chris Heery

Chief Medical Officer

Precision BioSciences

Dan Miskimin

Technical Director

Juno Therapeutics

Donna McLaren

Senior Director

Orchard Therapeutics

Elena Armenteros Monterroso

Lead Translational Scientist

UCL Institute of Child Health

Eleni Chantzoura

Associate Director, Immune Receptor Discovery

AgenTus Therapeutics

Federico Mingozzi

Chief Scientific Officer

Spark Therapeutics

Francis Szele

Associate Professor of Developmental Biology

University of Oxford

Frank Thielmann

Operational Excellence Director - Region Europe

Takeda

Hans Keirstead

Chief Executive Officer

Aivita Biomedical

Hans-Juergen Fuelle

Global Therapeutic Area Lead RA Pharmaceuticals GDD, NIBR DA Lead OPH & DAx for Early Development Regulatory Affairs

Novartis

Hugo Vankelecom

Professor

University of Leuven

Hy Levitsky

President of Research & Development

Century Therapeutics

Igor Rudychev

Head of Data & Innovations, Global Commercial Innovation

AstraZeneca

Jacob Sten Peterson

Corporate Vice President

Novo Nordisk

Jak Knowles

Vice President, Venture Investments

Bayer

James Ware

Associate Director, Purification Development & Lab Operations

Pfenex Biopharmaceuticals

Janet Glassford

Senior Quality Assessor, Biological/Biotechnology Unit

MHRA

Joachim Baer

Director, Cell Culture Development

Boehringer Ingelheim Corporate Center GmbH

Joanna Kawalkowska

Senior Scientist - Cell & Gene Therapy

GammaDelta Tx

John Rossi

Senior Director, Head of Cell Therapy Clinical Pharmacology

Kite, A Gilead Company

Jolanda Gerritsen

Assistant Director, Cell Line Development

Genmab

Jonathon Orme

Associate Director

AstraZeneca

Kelsey Reger

R&D Scientist

Merck KGaA

Khalid Shah

Director, Center for Stem Cell Therapeutics and imaging

Harvard Medical School

Knut Niss

Chief Technical Officer

Mustang Bio

Laure Twyffels

Senior Scientist, R&D

Celyad

Len Pattenden

Head of Biotherapeutics Development & Drug Supply

Cancer Research UK

Lior Raviv

Vice President

Pluristem

Marina Tarunina

Research Director

Plasticell

Matt Petroff

Senior Scientist

Spark Therapeutics

Michael Boychyn

Vice President, Process Development

REGENXBIO

Michael Lanero Fidalgo

Chief Operations Officer

TreeFrog Therapeutics

Min Wei

Director/Fellow

AstraZeneca

Mohamed Essameldin Abdelgawad

Associate Professor and Group Leader

Inserm

Mohammed Asmal

Vice Presdient and Head of Clinical Research & Development

bluebird bio

Mona Bausch

Scientist, Perfusion / Cell Culture Media

Merck KGaA

Mukesh Mayani

Principal Scientist - Gene Therapy

Sanofi

Nicholas Forsyth

Professor of Stem Cell Biology

Keele University

Nick Li

Senior Director, Health Economics & Outcomes Research

uniQure

Nina Kotsopoulou

Vice President, Cell & Gene Therapy

Orchard Therapeutics

Palani Palaniappan

Chief Technical Officer

Aruvant

Patrick Hanley

Director GMP for Immunotherapy

Children's National Medical Center

Pedro Campino

Director, Senior Global Regulatory Lead, Gene Therapies

CSL Behring

Petra Kaufmann

Vice President, R&D Translational Medicine

Novartis Gene Therapy

Qasim Rafiq

Associate Professor

UCL

Qi Cai

Senior Scientist, Lead of Non-Viral Vector Delivery Project

Kite, A Gilead Company

Regina Fritsche Danielson

Senior Vice President and Global Head of Research and Early Clinical Development, Cardiovascular, Renal and Metabolic Diseases

AstraZeneca

Rhiannon David

Scientific Lead for Microphysiological Systems

AstraZeneca

Ricardo Silva

Senior Scientist

iBET-Instituto de Biologia Experimental e Tecnologica

Rolf Koehler

Group Head CLD1

Novartis

Ron Bates

Director

Bristol-Myers Squibb

Rosemary Versteegen

Chief Executive Officer

International Serum Industry Association (ISIA)

Sabine Cholsta

Chief Medical Officer

Triumvira Immunologics

Sakis Mantalaris

Professor of Biomedical Engineering

Georgia Institute of Technology

Samantha Vieira

Executive Director

Biogen

Sarah Snykers

QC Manager

Celyad

Seshu Tyagarajan

CMC Team Leader

Novartis

Sharon Longhurst

Head of CMC

Immunicum

Shree Patel

Senior Vice President, Clinical Operations

Achilles Therapeutics

Stefano Pluchino

Chief Scientific Officer

iSTEM Therapeutics

Ta-Chun Hang

Senior Scientist

bluebird bio

Tania Incitti

Senior Research Scientist

AstraZeneca

Thierry Zeigler

Senior Director

Cellectis

Tony D’Amore

Vice President, Product Research & Development

Sanofi

Ulrich Ruemenapp

Head of Launch Preparation and Coordination

Bayer AG

Uwe Demelbauer

Global Head Drug Substance Development, Operational Sciences Mammalian

Novartis

Vincent Dewar

Lead Monoclonal Antibodies Platform, Senior Manager

GlaxoSmithKline

Yun Tang

Head of Cell Therapy Development Operations

Juno Therapeutics

Yuval Shimoni

Principal Scientist

Bayer AG

: Speakers

Speakers

Attracting leading experts & the brightest minds in the industry to educate, inform and excite our attendees.

The following were confirmed speakers for the 2020 Series.

Contact Us:

Copyright Oxford Global Marketing Limited. All rights reserved.

Download Brochure

Full details regarding Cell Series UK: Virtual are available for download in the Conference Brochure